Biotech (new drugs) stocks

바이오 신약

What are Biotech (new drugs) stocks in Korea?

The Biotech (new drugs) theme on jonbur groups 190 Korean stocks listed on KOSPI and KOSDAQ, worth ₩212T in total. On Oct 30, 2026 the group moved up 2.36% (weighted by market value); the largest members are Samsung Biologics, Celltrion, Alteogen.

Stocks: 190
Total market value: ₩212T
Day's move: +2.36%
As of: Oct 30, 2026
Largest members: Samsung Biologics, Celltrion, Alteogen

Earnings tracker · 3Q 2026

Reporting season · reports due by Nov 14

7 of 194 reportedOperating profit up vs a year ago: 5 of 6

Revenue+22.5%

Operating profit+52.3%

Net profitTurned to profit

Combined, for the companies that have reported, vs the same quarter a year ago

Company	Reported	Revenue	vs a year ago	Operating profit	vs a year ago	vs last quarter	Op. margin
Celltrion	Oct 12Preliminary	₩1.5T	+45.8%	₩510B	+69.2%	+12.9%	34.0%29.3%
Yuhan	Oct 28Preliminary	₩586B	+2.8%	₩35B	+57.8%	−48.0%	5.9%3.9%
Hanmi Pharm	Oct 27Preliminary	₩377B	+4.2%	₩38B	−31.3%	−71.2%	10.0%15.2%
ST Pharm	Oct 27Preliminary	₩98B	+19.1%	₩16B	+6.6%	−14.3%	16.1%18.0%
Bukwang Pharmaceutical IND	Oct 23Preliminary	₩58B	+21.2%	₩2.2B	+120.7%	+53.3%	3.7%2.0%
Dong-A ST	Oct 27Preliminary	₩207B	−4.4%	₩21B	+52.9%	+239.9%	10.4%6.5%
T&R Biofab	Oct 19Preliminary	₩8.9B	+28.1%	—	—	—	—
Samsung Biologics	Expected around Oct 28
Hanall Biopharma	Expected around Oct 29
Onconic Therapeutics	Expected around Oct 30
Bioneercorporation	Expected around Oct 31
Abion	Expected around Oct 31
SK Bioscience	Expected around Nov 3
GC Biopharma	Expected around Nov 3
Chong Kun Dang Pharmaceutical	Expected around Nov 3
GC Cell	Expected around Nov 3
Choong ANG Vaccine Laboratory	Expected around Nov 3
GC Medical Science	Expected around Nov 3
Hugel	Expected around Nov 4
SK biopharmaceuticals	Expected around Nov 5
JW Shinyak	Expected around Nov 5
IL Dong Pharmaceutical	Expected around Nov 6
ISU Abxis	Expected around Nov 6
Cell Biotech	Expected around Nov 6
Seegene	Expected around Nov 7
Daewoong Pharma	Expected around Nov 7
NeoImmuneTech	Expected around Nov 7
QuadMedicine	Expected around Nov 7
Medy-Tox	Expected around Nov 10
AbClon	Expected around Nov 10
EuBiologics	Expected around Nov 10
Vivozon Pharmaceutical	Expected around Nov 10
Eye Gene	Expected around Nov 10
Daesung Microbiological Labs	Expected around Nov 10
PharmaResearch	Expected around Nov 11
ABL Bio	Expected around Nov 11
Rznomics	Expected around Nov 11
Pharos iBio	Expected around Nov 11
Olipass	Expected around Nov 11
OSCOTECInc	Expected around Nov 12
MedPacto	Expected around Nov 12
Gencurix	Expected around Nov 12
Chabiotech	Expected around Nov 13
G2GBIO	Expected around Nov 13
Pharmicell	Expected around Nov 13
Curocell	Expected around Nov 13
AprilBio	Expected around Nov 13
Kangstem Biotech	Expected around Nov 13
DuChemBio	Expected around Nov 13
3billion	Expected around Nov 13
Ilyang Pharmaceutical	Expected around Nov 13
Genexine	Expected around Nov 13
DreamCIS	Expected around Nov 13
Aribiolab	Expected around Nov 13
ViGenCell	Expected around Nov 13
DongKook Life Science	Expected around Nov 13
SunBio	Expected around Nov 13
Pangen Biotech	Expected around Nov 13
Cytogen	Expected around Nov 13
KoBioLabs	Expected around Nov 13
Aprogen Biologics	Expected around Nov 13
Wonbiogen	Expected around Nov 13
Eutilex	Expected around Nov 13
Biotoxtech	Expected around Nov 13
Alteogen	Expected around Nov 14
HLB	Expected around Nov 14
LigaChem Biosciences	Expected around Nov 14
Peptron	Expected around Nov 14
OliX Pharmaceuticals	Expected around Nov 14
Voronoi	Expected around Nov 14
Caregen	Expected around Nov 14
Mezzion Pharma	Expected around Nov 14
Naturecell	Expected around Nov 14
Kolon TissueGene	Expected around Nov 14
Daewoong	Expected around Nov 14
JS Link	Expected around Nov 14
L&C Bio	Expected around Nov 14
Qurient	Expected around Nov 14
Proteina	Expected around Nov 14
Hyundai Bioscience	Expected around Nov 14
Shinpoong Pharmaceutical	Expected around Nov 14
GI Innovation	Expected around Nov 14
HLB Pharmaceutical	Expected around Nov 14
HLB Life Science	Expected around Nov 14
GemVax & KAEL	Expected around Nov 14
Penetrium Bioscience	Expected around Nov 14
Orum Therapeutics	Expected around Nov 14
Medipostco	Expected around Nov 14
ToolGen	Expected around Nov 14
SillaJen	Expected around Nov 14
NKGen Biotech Korea	Expected around Nov 14
Q AID	Expected around Nov 14
Genomictree	Expected around Nov 14
S.Biomedics	Expected around Nov 14
HLB Therapeutics	Expected around Nov 14
ImmuneOncia Therapeutics	Expected around Nov 14
IntoCell	Expected around Nov 14
GC Genome	Expected around Nov 14
FutureChem	Expected around Nov 14
BioPlus	Expected around Nov 14
Binex	Expected around Nov 14
Genome&Company	Expected around Nov 14
curacle	Expected around Nov 14
Helixmith	Expected around Nov 14
Eone Diagnomics Genome Center	Expected around Nov 14
Kolon Life Science	Expected around Nov 14
BNC Korea	Expected around Nov 14
Cellbion	Expected around Nov 14
Aptabio Therapeutics	Expected around Nov 14
Bio Solution	Expected around Nov 14
Aribio Holdings	Expected around Nov 14
Y-Biologics	Expected around Nov 14
Anterogen	Expected around Nov 14
Macrogen	Expected around Nov 14
TiumBio	Expected around Nov 14
Celemics	Expected around Nov 14
Keeps Biopharma	Expected around Nov 14
Asta	Expected around Nov 14
HLB bioStep	Expected around Nov 14
Aminologics	Expected around Nov 14
HLB Global	Expected around Nov 14
Vaxcell-Bio Therapeutics	Expected around Nov 14
Corestemchemon	Expected around Nov 14
iNtRON Biotechnology	Expected around Nov 14
Cellumed	Expected around Nov 14
Enzychem Lifesciences	Expected around Nov 14
HLB Genex	Expected around Nov 14
SCL Science	Expected around Nov 14
Theragen Etex	Expected around Nov 14
Daebonglsco	Expected around Nov 14
Choolip & Sciences	Expected around Nov 14
Sugentech	Expected around Nov 14
Amicogen	Expected around Nov 14
CG Invites	Expected around Nov 14
PharmGen Science	Expected around Nov 14
Optipharm	Expected around Nov 14
Adbiotech	Expected around Nov 14
HLB Panagene	Expected around Nov 14
Tego Science	Expected around Nov 14
ENCell	Expected around Nov 14
GeneOne Life Science	Expected around Nov 14
CJ Bioscience	Expected around Nov 14
Aprogen	Expected around Nov 14
Geninus	Expected around Nov 14
Inbiogen	Expected around Nov 14
Quratis	Expected around Nov 14
RPbio	Expected around Nov 14
Green Lifescience	Expected around Nov 14
Oncocross	Expected around Nov 14
HLB Pep	Expected around Nov 14
Kainos Medicine	Expected around Nov 14
Organoidsciences	Expected around Nov 14
Orientbio	Expected around Nov 14
Kolmar BioTech	Expected around Nov 14
SeouLin Bioscience	Expected around Nov 14
Genolution	Expected around Nov 14
Hass	Expected around Nov 14
LabGenomics	Expected around Nov 14
SLSBio(Specialty Lab Solution Bio)	Expected around Nov 14
Genematrix	Expected around Nov 14
C&R Research	Expected around Nov 14
GFC Life Science	Expected around Nov 14
MFC	Expected around Nov 14
WooGene B&Gco	Expected around Nov 14
Jeonjinbio	Expected around Nov 14
Xcell Therapeutics	Expected around Nov 14
PeopleBio	Expected around Nov 14
Celestra	Expected around Nov 14
From Bio	Expected around Nov 14
BioInfra	Expected around Nov 14
MOA Life Plus	Expected around Nov 14
208340	Expected around Nov 14
Prestige BioPharma	Expected around Nov 28
Aimed Bio	Not yet
Ingenia Therapeutics	Not yet
Samyang Biopharm	Not yet
Ensol Biosciences	Not yet
Kanaph Therapeutics	Not yet
Inventera	Not yet
HL Genomics	Not yet
NovMetaPharma	Not yet
Epi Biotech	Not yet
ProGen	Not yet
Plumbline Life Sciences	Not yet
Moogene Medi	Not yet
Curachem	Not yet
Invites Biocore	Not yet
Median Diagnostics	Not yet
Cronex	Not yet
BioInfra Life Science	Not yet
341170	Not yet
283100	Not yet
258540	Not yet
072520	Not yet

Single-quarter figures. Preliminary figures are the company's own early numbers and are replaced by the quarterly report when it's filed. Expected dates are around when each company reported a year ago.

Technical breadth

After the close on Oct 30, 2026

Above 20-day average: 8%
Above 60-day average: 17.3%
RSI above 70: 0.6%
RSI below 30: 14.8%
52-week highs: 0
52-week lows: 27

Index gauge · Short term

Bearish

0 bullish, 2 neutral, 7 bearish

Index gauge · Medium term

Bearish

0 bullish, 1 neutral, 7 bearish

Technical read

The Biotech (new drugs) theme covers 162 members, and only 8 percent of them sit above their 20-day average while 17.3 percent are above their 60-day average. Across the group, 0 stocks are at 52-week highs and 27 are at 52-week lows, with RSI readings running from an extreme low of 14.8 to a high of 0.6. The equal-weighted member index is labeled bearish on both the short and medium horizons, with its RSI at 32.6 and its price positioned below the cloud.

Written by AI from the indicator values above. Not advice.

Share of members, from each member's own indicators; the gauge reads an equal-weighted index of the members. Technical indicators describe past price and volume patterns. They are not predictions or recommendations.

Credit & macro

MaturitiesOct 23, 202685ISU Abxis: ₩50bn of bonds due in the next 6 months vs ₩23bn cash₩50bn due within 12 months, from the bond filings so far; cash and cash equivalents as of 2026 H1.ISU Abxis
MaturitiesOct 23, 202685GC Biopharma: ₩130bn of bonds due in the next 6 months vs ₩42bn cash₩130bn due within 12 months, from the bond filings so far; cash and cash equivalents as of 2026 H1.GC Biopharma
MaturitiesOct 20, 202685SK Reit: ₩130bn of bonds due in the next 6 months vs ₩54bn cash₩350bn due within 12 months, from the bond filings so far; cash and cash equivalents as of 2025 FY.SK Reit SK hynix SK Networks SK Discovery SKC SK Telecom

ETFs for this theme

All ETFs →

AUM · Flow 1w

Creators talking about this

Doctors begin to prescribe country’s first domestically developed obesity drug on Thurs.Arirang News · via YouTube

Biotech (new drugs)

−1.71%

바이오 신약

The Biotech (new drugs) theme in Korea covers companies that research, develop, and commercialize novel pharmaceutical drugs, including small-molecule compounds, biologics, and next-generation therapies such as antibody and cell treatments. Korean investors often group these firms together because they share a long development timeline, heavy R&D spending, and milestones tied to clinical trials, regulatory approvals, and licensing deals with global pharmaceutical companies. The theme is distinct from generic drug manufacturers and from contract manufacturing businesses, though some companies operate in several of these areas.

190 companies · 36 up · 22 flat · 132 down

Traded value: ₩781B
Value vs 20-day average: 0.88×
Top gainer: NovMetaPharma
Largest company: Samsung Biologics

Companies in this theme

Market cap Value traded Gainers Losers NPS stake

All KOSPI KOSDAQ

NPS owns > 5%

Company	Price	Daily	Traded value	Market cap	NPS
Alteogen196170 · KOSDAQ	₩211,500	−3.86%	₩71B	₩15T	2.68%
HLB028300 · KOSDAQ	₩40,000	+0.76%	₩30B	₩5.3T	1.16%
LigaChem Biosciences141080 · KOSDAQ	₩61,500	−3.91%	₩8.6B	₩2.3T	4.99%
Hugel145020 · KOSDAQ	₩179,800	−1.91%	₩6.4B	₩2.3T	2.29%
PharmaResearch214450 · KOSDAQ	₩212,000	−4.72%	₩17B	₩2.2T	7.14%
ABL Bio298380 · KOSDAQ	₩39,200	−4.39%	₩11B	₩2.2T	4.02%
Peptron087010 · KOSDAQ	₩92,300	−5.04%	₩14B	₩2.2T	1.63%
OliX Pharmaceuticals226950 · KOSDAQ	₩94,000	−2.59%	₩15B	₩2.2T	5.04%
Voronoi310210 · KOSDAQ	₩106,100	−7.90%	₩9.3B	₩2T	2.78%
Caregen214370 · KOSDAQ	₩33,150	−2.36%	₩2B	₩1.8T	0.65%
Mezzion Pharma140410 · KOSDAQ	₩51,200	−2.66%	₩4.8B	₩1.6T	0.50%
Seegene096530 · KOSDAQ	₩33,250	−1.04%	₩5.6B	₩1.6T	0.64%
ST Pharm237690 · KOSDAQ	₩72,500	−2.03%	₩8.5B	₩1.5T	5.77%
Naturecell007390 · KOSDAQ	₩21,800	−1.80%	₩2.7B	₩1.4T	0.44%
OSCOTECInc039200 · KOSDAQ	₩36,450	−0.14%	₩4.5B	₩1.4T	3.87%
Aimed Bio0009K0 · KOSDAQ	₩18,860	−4.99%	₩3.1B	₩1.2T	0.03%
Kolon TissueGene950160 · KOSDAQ	₩13,920	−2.66%	₩3.3B	₩1.2T	0.57%
Ingenia Therapeutics950260 · KOSDAQ	₩22,350	−4.89%	₩3.2B	₩1.1T	—
JS Link127120 · KOSDAQ	₩18,230	−5.05%	₩3.4B	₩682B	5.05%
L&C Bio290650 · KOSDAQ	₩23,950	−4.58%	₩5.5B	₩646B	1.28%
Chabiotech085660 · KOSDAQ	₩6,750	−0.15%	₩1B	₩628B	0.31%
Qurient115180 · KOSDAQ	₩16,590	−6.95%	₩1.4B	₩623B	3.88%
Proteina468530 · KOSDAQ	₩54,300	+0.74%	₩13B	₩603B	3.78%
Rznomics476830 · KOSDAQ	₩21,300	−5.96%	₩6.4B	₩600B	3.96%
G2GBIO456160 · KOSDAQ	₩35,600	−2.73%	₩8B	₩592B	2.41%
Onconic Therapeutics476060 · KOSDAQ	₩12,110	−4.04%	₩2B	₩550B	—
Hyundai Bioscience048410 · KOSDAQ	₩5,370	−5.29%	₩6B	₩518B	0.37%
Medy-Tox086900 · KOSDAQ	₩63,900	−0.47%	₩624M	₩466B	1.44%
GI Innovation358570 · KOSDAQ	₩6,730	−3.03%	₩2.3B	₩434B	4.07%
HLB Pharmaceutical047920 · KOSDAQ	₩9,500	−0.11%	₩9.5B	₩414B	—
HLB Life Science067630 · KOSDAQ	₩3,295	+0.46%	₩489M	₩402B	0.07%
GemVax & KAEL082270 · KOSDAQ	₩8,650	−4.42%	₩1.3B	₩393B	2.55%
Penetrium Bioscience187660 · KOSDAQ	₩6,100	−1.13%	₩3.1B	₩390B	—
AbClon174900 · KOSDAQ	₩18,470	−5.81%	₩5.4B	₩369B	3.57%
Curocell372320 · KOSDAQ	₩23,050	−2.74%	₩514M	₩351B	0.46%
Orum Therapeutics475830 · KOSDAQ	₩15,320	−3.10%	₩2.5B	₩333B	0.09%
AprilBio397030 · KOSDAQ	₩11,810	−4.76%	₩3B	₩325B	0.95%
Medipostco078160 · KOSDAQ	₩8,090	−3.11%	₩485M	₩317B	1.55%
ToolGen199800 · KOSDAQ	₩29,200	−5.65%	₩1.1B	₩285B	0.43%
EuBiologics206650 · KOSDAQ	₩7,730	−0.90%	₩598M	₩281B	0.17%
SillaJen215600 · KOSDAQ	₩2,020	−1.94%	₩871M	₩280B	0.09%
NKGen Biotech Korea182400 · KOSDAQ	₩3,670	0.00%	₩0	₩265B	—
Q AID377460 · KOSDAQ	₩4,080	0.00%	₩0	₩253B	—
Genomictree228760 · KOSDAQ	₩9,970	+0.71%	₩580M	₩248B	0.51%
S.Biomedics304360 · KOSDAQ	₩19,190	−2.09%	₩468M	₩240B	—
HLB Therapeutics115450 · KOSDAQ	₩2,495	−2.54%	₩1.7B	₩236B	0.10%
ImmuneOncia Therapeutics424870 · KOSDAQ	₩2,515	−3.27%	₩925M	₩230B	—
IntoCell287840 · KOSDAQ	₩14,890	−4.12%	₩275M	₩224B	1.04%
GC Genome340450 · KOSDAQ	₩9,100	+6.06%	₩22B	₩215B	—
FutureChem220100 · KOSDAQ	₩6,930	−7.35%	₩1.6B	₩215B	0.76%
BioPlus099430 · KOSDAQ	₩3,200	−6.16%	₩528M	₩197B	0.42%
Binex053030 · KOSDAQ	₩6,030	−0.82%	₩446M	₩197B	2.17%
Genome&Company314130 · KOSDAQ	₩3,505	−3.71%	₩773M	₩188B	0.24%
Vivozon Pharmaceutical082800 · KOSDAQ	₩3,095	+5.45%	₩792M	₩188B	—
curacle365270 · KOSDAQ	₩7,950	−0.87%	₩122M	₩176B	0.50%
Kangstem Biotech217730 · KOSDAQ	₩1,872	−1.42%	₩598M	₩176B	0.10%
Bioneercorporation064550 · KOSDAQ	₩6,810	−2.44%	₩927M	₩176B	0.10%
DuChemBio176750 · KOSDAQ	₩6,090	−4.84%	₩1.2B	₩173B	0.04%
Helixmith084990 · KOSDAQ	₩3,700	+2.21%	₩493M	₩171B	0.12%
3billion394800 · KOSDAQ	₩5,350	−13.01%	₩3.4B	₩170B	4.02%
Eone Diagnomics Genome Center245620 · KOSDAQ	₩741	0.00%	₩0	₩167B	—
Kolon Life Science102940 · KOSDAQ	₩12,410	−3.27%	₩784M	₩162B	0.50%
BNC Korea256840 · KOSDAQ	₩2,350	−3.29%	₩1B	₩161B	—
GC Cell144510 · KOSDAQ	₩10,100	+3.59%	₩728M	₩160B	0.06%
Cellbion308430 · KOSDAQ	₩11,670	−8.25%	₩220M	₩151B	—
Aptabio Therapeutics293780 · KOSDAQ	₩5,090	−4.14%	₩358M	₩143B	0.05%
ISU Abxis086890 · KOSDAQ	₩3,435	−1.58%	₩201M	₩140B	0.20%
Bio Solution086820 · KOSDAQ	₩5,370	−1.65%	₩194M	₩139B	0.15%
Cell Biotech049960 · KOSDAQ	₩14,800	0.00%	₩71M	₩139B	0.00%
Aribio Holdings290690 · KOSDAQ	₩2,620	−2.42%	₩634M	₩139B	—
Y-Biologics338840 · KOSDAQ	₩8,950	−3.24%	₩623M	₩138B	0.17%
Anterogen065660 · KOSDAQ	₩13,360	−5.11%	₩556M	₩134B	0.30%
JW Shinyak067290 · KOSDAQ	₩2,220	−3.48%	₩2.6B	₩124B	—
Kanaph Therapeutics0082N0 · KOSDAQ	₩9,100	−5.70%	₩599M	₩121B	—
Macrogen038290 · KOSDAQ	₩10,900	−0.46%	₩115M	₩118B	4.56%
TiumBio321550 · KOSDAQ	₩3,635	−2.15%	₩863M	₩109B	0.31%
MedPacto235980 · KOSDAQ	₩3,050	+2.69%	₩306M	₩105B	2.96%
Celemics331920 · KOSDAQ	₩9,230	+0.11%	₩792M	₩103B	—
Keeps Biopharma256940 · KOSDAQ	₩5,100	−3.95%	₩239M	₩102B	—
Asta246720 · KOSDAQ	₩6,070	0.00%	₩0	₩99B	—
Genexine095700 · KOSDAQ	₩2,160	−0.23%	₩318M	₩98B	0.15%
DreamCIS223250 · KOSDAQ	₩3,990	−0.25%	₩1.4B	₩98B	—
Aribiolab261780 · KOSDAQ	₩3,350	+0.15%	₩661M	₩97B	—
ViGenCell308080 · KOSDAQ	₩4,655	−4.41%	₩399M	₩95B	0.59%
HLB bioStep278650 · KOSDAQ	₩5,290	+0.76%	₩9.5B	₩92B	—
Aminologics074430 · KOSDAQ	₩1,009	+0.90%	₩85M	₩90B	—
T&R Biofab246710 · KOSDAQ	₩1,820	−3.04%	₩522M	₩87B	0.95%
Vaxcell-Bio Therapeutics323990 · KOSDAQ	₩3,725	−1.72%	₩211M	₩87B	0.07%
Corestemchemon166480 · KOSDAQ	₩1,636	−1.45%	₩91M	₩86B	0.02%
iNtRON Biotechnology048530 · KOSDAQ	₩2,790	−2.96%	₩375M	₩86B	1.38%
Cellumed049180 · KOSDAQ	₩1,009	0.00%	₩0	₩84B	—
Enzychem Lifesciences183490 · KOSDAQ	₩990	0.00%	₩0	₩84B	0.30%
Choong ANG Vaccine Laboratory072020 · KOSDAQ	₩8,810	−0.68%	₩72M	₩82B	—
HLB Genex187420 · KOSDAQ	₩2,360	+4.66%	₩625M	₩77B	—
SCL Science246960 · KOSDAQ	₩2,140	−3.17%	₩373M	₩74B	—
GC Medical Science142280 · KOSDAQ	₩3,085	−2.37%	₩1.6B	₩74B	—
Eye Gene185490 · KOSDAQ	₩1,705	−2.57%	₩69M	₩74B	2.40%
Theragen Etex066700 · KOSDAQ	₩1,980	+0.25%	₩60M	₩73B	0.40%
Daebonglsco078140 · KOSDAQ	₩6,550	−1.36%	₩79M	₩73B	2.30%
Choolip & Sciences291650 · KOSDAQ	₩2,375	+3.26%	₩78M	₩72B	—
Pharos iBio388870 · KOSDAQ	₩5,580	−3.46%	₩153M	₩72B	—
Sugentech253840 · KOSDAQ	₩4,060	−0.61%	₩179M	₩68B	—
DongKook Life Science303810 · KOSDAQ	₩2,095	−2.33%	₩508M	₩67B	—
Amicogen092040 · KOSDAQ	₩916	+1.10%	₩349M	₩65B	0.37%
CG Invites083790 · KOSDAQ	₩841	−4.10%	₩106M	₩65B	—
SunBio067370 · KOSDAQ	₩5,250	−5.06%	₩14M	₩64B	—
Inventera0007J0 · KOSDAQ	₩7,920	−5.04%	₩419M	₩62B	—
Optipharm153710 · KOSDAQ	₩4,245	−2.30%	₩34M	₩62B	0.44%
Abion203400 · KOSDAQ	₩3,380	0.00%	₩0	₩61B	0.98%
Adbiotech179530 · KOSDAQ	₩1,886	−2.28%	₩50M	₩59B	—
Pangen Biotech222110 · KOSDAQ	₩4,285	−7.05%	₩92M	₩58B	—
HLB Panagene046210 · KOSDAQ	₩1,259	−0.47%	₩291M	₩57B	—
Tego Science191420 · KOSDAQ	₩7,040	−3.03%	₩8.1M	₩57B	—
HL Genomics0156T0 · KOSDAQ	₩7,000	−1.69%	₩229M	₩54B	—
NeoImmuneTech950220 · KOSDAQ	₩1,576	−3.43%	₩199M	₩54B	—
Cytogen217330 · KOSDAQ	₩2,315	−1.28%	₩125M	₩54B	—
KoBioLabs348150 · KOSDAQ	₩2,670	−1.84%	₩27M	₩52B	—
ENCell456070 · KOSDAQ	₩4,675	−3.81%	₩198M	₩52B	—
CJ Bioscience311690 · KOSDAQ	₩3,695	+0.14%	₩11M	₩48B	—
QuadMedicine464490 · KOSDAQ	₩4,150	+0.61%	₩142M	₩48B	—
Geninus389030 · KOSDAQ	₩1,183	−5.36%	₩625M	₩47B	—
Gencurix229000 · KOSDAQ	₩1,957	0.00%	₩0	₩46B	0.81%
Quratis348080 · KOSDAQ	₩3,515	0.00%	₩49M	₩45B	—
RPbio314140 · KOSDAQ	₩5,080	−3.24%	₩20M	₩44B	—
Green Lifescience114450 · KOSDAQ	₩1,990	−1.97%	₩209M	₩40B	—
Wonbiogen307280 · KOSDAQ	₩5,500	−2.14%	₩103M	₩39B	—
Oncocross382150 · KOSDAQ	₩2,875	−5.12%	₩135M	₩38B	—
HLB Pep196300 · KOSDAQ	₩3,810	−6.27%	₩65M	₩36B	—
Kainos Medicine284620 · KOSDAQ	₩1,087	0.00%	₩0	₩36B	—
Organoidsciences476040 · KOSDAQ	₩5,460	−3.87%	₩89M	₩36B	1.38%
Eutilex263050 · KOSDAQ	₩959	0.00%	₩0	₩35B	0.74%
Kolmar BioTech215380 · KOSDAQ	₩2,045	−3.76%	₩48M	₩34B	—
SeouLin Bioscience038070 · KOSDAQ	₩3,565	−1.11%	₩26M	₩33B	—
Genolution225220 · KOSDAQ	₩1,724	+0.23%	₩105M	₩33B	—
Hass450330 · KOSDAQ	₩3,975	−2.69%	₩11M	₩33B	—
Biotoxtech086040 · KOSDAQ	₩1,999	−1.53%	₩28M	₩32B	—
LabGenomics084650 · KOSDAQ	₩2,095	+4.23%	₩94M	₩31B	0.58%
SLSBio(Specialty Lab Solution Bio)246250 · KOSDAQ	₩1,969	0.00%	₩0	₩30B	—
Genematrix109820 · KOSDAQ	₩1,403	−1.13%	₩63M	₩29B	—
C&R Research359090 · KOSDAQ	₩2,120	−4.29%	₩7.5M	₩24B	—
GFC Life Science388610 · KOSDAQ	₩4,275	−3.82%	₩76M	₩23B	—
Daesung Microbiological Labs036480 · KOSDAQ	₩5,490	−0.54%	₩7.4M	₩21B	—
MFC432980 · KOSDAQ	₩2,245	−1.97%	₩6.4M	₩19B	—
WooGene B&Gco018620 · KOSDAQ	₩2,760	−4.33%	₩48M	₩19B	—
Jeonjinbio110020 · KOSDAQ	₩2,050	0.00%	₩17M	₩19B	—
Xcell Therapeutics373110 · KOSDAQ	₩973	−2.51%	₩24M	₩17B	—
PeopleBio304840 · KOSDAQ	₩561	0.00%	₩0	₩14B	—
Celestra352770 · KOSDAQ	₩5,250	0.00%	₩0	₩14B	—
Olipass244460 · KOSDAQ	₩1,651	0.00%	₩0	₩13B	—
From Bio377220 · KOSDAQ	₩1,760	−6.48%	₩85M	₩10B	—
BioInfra199730 · KOSDAQ	₩1,350	−0.88%	₩298M	₩6.6B	—
MOA Life Plus142760 · KOSDAQ	₩220	−6.78%	₩202M	₩4.6B	—

Source: KRX statistical information